Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Cerilliant
Baxter
Teva
Johnson and Johnson
Express Scripts
AstraZeneca
Mallinckrodt
Argus Health
Queensland Health

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060611

« Back to Dashboard

NDA 060611 describes NEO-MEDROL ACETATE, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the NEO-MEDROL ACETATE profile page.

The generic ingredient in NEO-MEDROL ACETATE is methylprednisolone acetate; neomycin sulfate. There are forty drug master file entries for this compound. Additional details are available on the methylprednisolone acetate; neomycin sulfate profile page.
Summary for 060611
Tradename:NEO-MEDROL ACETATE
Applicant:Pharmacia And Upjohn
Ingredient:methylprednisolone acetate; neomycin sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength1%;EQ 3.5MG BASE/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CREAM;TOPICALStrength0.25%;EQ 3.5MG BASE/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Argus Health
Chubb
McKinsey
Deloitte
Mallinckrodt
Dow
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot